Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,069 | 35,227 | 95,891 | 98,182 | 216,545 |
| Receivables | 545,790 | 742,291 | 630,433 | 690,187 | 539,484 |
| Inventories | 529,042 | 530,735 | 543,858 | 533,028 | 512,241 |
| TOTAL | $1,307,325 | $1,411,818 | $1,419,832 | $1,553,601 | $1,389,678 |
| Non-Current Assets | |||||
| PPE Net | 462,606 | 469,815 | 470,150 | 483,625 | 500,911 |
| Intangibles | 1,654,475 | 1,694,946 | 1,758,509 | 1,805,198 | 1,812,711 |
| Other Non-Current Assets | 202,199 | 222,762 | 225,548 | 198,981 | 185,668 |
| TOTAL | $2,319,280 | $2,387,523 | $2,454,207 | $2,487,804 | $2,499,290 |
| Total Assets | $3,626,605 | $3,799,341 | $3,874,039 | $4,041,405 | $3,888,968 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 129,965 | 89,961 | 89,940 | 114,920 | 30,523 |
| Accounts payable and accrued liabilities | 482,171 | 540,678 | 535,329 | 586,596 | 555,694 |
| Other current liabilities | N/A | 107,483 | 176,094 | 275,338 | N/A |
| TOTAL | $703,709 | $752,800 | $817,995 | $993,064 | $602,043 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,601,852 | 2,631,687 | 2,646,496 | 2,661,303 | 2,711,104 |
| Other Non-Current Liabilities | 189,527 | 232,400 | 214,960 | 333,320 | 172,718 |
| TOTAL | $2,788,228 | $2,862,562 | $2,861,755 | $2,875,350 | $2,879,518 |
| Total Liabilities | $3,491,937 | $3,615,362 | $3,679,750 | $3,868,414 | $3,481,561 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 305,454 | 303,618 | 303,593 | 303,525 | 302,924 |
| Common Shares | 3,054 | 3,036 | 3,035 | 3,032 | 3,028 |
| Retained earnings | -413,126 | -406,183 | -401,850 | -399,161 | -278,353 |
| Other shareholders' equity | -155,982 | -104,503 | -90,641 | -106,468 | 15,933 |
| TOTAL | $134,668 | $183,979 | $194,289 | $172,991 | $407,407 |
| Total Liabilities And Equity | $3,626,605 | $3,799,341 | $3,874,039 | $4,041,405 | $3,888,968 |